Identifying Malnutrition in Overweight Adults
SCreening fOr Malnutrition and Obesity in Patients With COVID-19 and Other Diseases
This study is trying to see if overweight adults can also be malnourished, especially those affected by COVID-19, and will create a simple tool to help doctors spot malnutrition in these patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | HAN University of Applied Sciences Academic / other |
| Locations | 3 sites (Amsterdam and 2 other locations) |
| Trial ID | NCT06626360 on ClinicalTrials.gov |
What this trial studies
This study aims to explore the coexistence of malnutrition and obesity in adults, particularly in the context of COVID-19 and cancer outcomes. It will involve literature and database research to identify parameters linked to worse disease outcomes and will develop a simple screening tool for recognizing malnutrition in overweight patients. The study will assess nutritional status and dietary treatment in primary care settings, focusing on patients with COVID-19. The findings could help improve clinical practices and patient care.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 years or older who are classified as overweight with a BMI of 25 kg/m² or higher.
Not a fit: Patients who are physically or mentally unable to participate, or those with severe cognitive disorders, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better identification and management of malnutrition in overweight patients, potentially improving health outcomes during COVID-19 and other diseases.
How similar studies have performed: While the approach of screening for malnutrition in overweight individuals is gaining attention, this specific combination of factors in relation to COVID-19 outcomes is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older * Overweight (BMI of 25 kg/m² or higher) Exclusion Criteria: * Physically or mentally unable to participate. * Severe cognitive disorder or severe emotional instability, as assessed by the attending nurse or physician. * Insufficient proficiency in the Dutch language to express themselves properly and no interpreter or assistant to help. * Patient resides in a nursing or care home.
Where this trial is running
Amsterdam and 2 other locations
- Olvg — Amsterdam, Netherlands (Recruiting)
- Ziekenhuis Gelderse Vallei — Ede, Netherlands (Recruiting)
- ErasmusMC — Rotterdam, Netherlands (Recruiting)
Study contacts
- Study coordinator: Marian A de van der Schueren, PhD
- Email: marian.devanderschueren@han.nl
- Phone: +31-024-353-0500
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.